Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 63431 record(s)

Req # A-2021-002142

Adverse Drug Reactions (ADRs) for ZOPICLONE, BUDESONIDE, QUADRIVALENT INFLUENZA VACCINE. Report numbers: E2B_04821402, E2B_04819777, E2B_04546577, 000974506.

Organization: Health Canada

47 page(s)
June 2022

Req # A-2021-002153

Adverse Drug Reactions (ADRs) for ALEMTUZUMAB, ALIROCUMAB, CABAZITAXEL, ENOXAPARIN SODIUM, FUROSEMIDE. Report numbers: 000967750, E2B_04898115, 000975008, E2B_04904547, E2B_04685448, 000976602, 000975238, E2B_04647826, E2B_04632578.

Organization: Health Canada

137 page(s)
June 2022

Req # A-2022-000001

Adverse Drug Reactions (ADRs) for METFORMIN, METFORMIN HYDROCHLORIDE, METOLAZONE, RANITIDINE. Report numbers: E2B_04799227, E2B_04906981, E2B_04913738, E2B_04888052, E2B_04781178, 000975040, E2B_04811723, E2B_04799802, E2B_04921453, E2B_04925972.

Organization: Health Canada

228 page(s)
June 2022

Req # A-2022-000004

Adverse Drug Reactions (ADRs) for METFORMIN, METFORMIN HYDROCHLORIDE, METOLAZONE, RANITIDINE. Report numbers: 000977292, E2B_03623086, E2B_04657718, E2B_04724520, 000973481, E2B_04683448, E2B_04683292.

Organization: Health Canada

237 page(s)
June 2022

Req # A-2022-000005

Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE, ZOPICLONE. Report numbers: E2B_04938746, E2B_04772196, E2B_04821402, E2B_04675804, E2B_04793351.

Organization: Health Canada

104 page(s)
June 2022

Req # A-2022-000010

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102424-617, Digital Transformation Branch Structure.

Organization: Health Canada

5 page(s)
June 2022

Req # A-2022-000013

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101702-725.

Organization: Health Canada

14 page(s)
June 2022

Req # A-2022-000028

Adverse Drug Reactions (ADRs). Report numbers: E2B_04704010, E2B_04718385, 970537, 970543, 971165, 971396, E2B_04773942, E2B_04774155, E2B_04751076, E2B_04763945.

Organization: Health Canada

69 page(s)
June 2022

Req # A-2022-000029

Adverse Drug Reactions (ADRs). Report numbers: 977404, E2B_04787155, E2B_04795026, E2B_04798528, 971605, 972249, 971392, 973210, 973216, E2B_04801281.

Organization: Health Canada

107 page(s)
June 2022

Req # A-2022-000053

Adverse Drug Reaction (ADR) for Duloxetine. Report number: E2B_03524643.

Organization: Health Canada

10 page(s)
June 2022
Date modified: